Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
This is a 100% increase over the number of companies cited in the previous quarter.
The citations in the county include:
- Written MDR procedures have not been maintained.
- Requirements that must be met by suppliers have not been adequately established.
- Corrective and preventive action activities and/or results have not been documented.
Most of the companies cited were involved in the Drugs sector. The second most common type of company cited in the time period worked in the .
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
A. M. Surgical, Inc. | Devices | 10/20/2023 | DMR - not or inadequately maintained |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Specifications - identity, purity, strength, composition |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Specifications met - identity, purity, strength, composition |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Component - verify identity, dietary ingredient |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Quality control - reject; specification not met |
AMP Nutraceuticals | Food and Cosmetics | 11/21/2023 | Standard reference materials; criteria for selecting |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | HACCP plan implementation |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Food safety hazards |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Critical limits |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Verification procedures - adequacy |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Signed and dated |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Corrective action per predetermined plan |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Verification - record review - frequency |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Sanitation monitoring |
Bob Gosman Company, Inc. | Food and Cosmetics | 10/19/2023 | Importer verification |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Procedure Deviations Recorded and Justified |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Actual vs. theoretical yields not determined |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Strict control not exercised over labeling issued |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Storage under appropriate conditions |
Madcar A Division of Century Direct Solutions | Drugs | 12/20/2023 | Labeling Control Records and Label Copies |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Following manufacturer's instructions |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Establish, maintain and follow manufacturing SOPs |
New York Blood Center Enterprises | Biologics | 12/22/2023 | Person performing, test results, interpretation |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Procedures not in writing, fully followed |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | GMP Training Frequency |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Equipment Design, Size and Location |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Written procedures not established/followed |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Component identity verification |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Absence of Written Procedures |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Expiration date lacking |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Record maintenance 1 year (except exempt OTC) |
Phoenix Wipes, Inc. | Drugs | 12/19/2023 | Records reviewed annually |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Computer control of master formula records |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Reports of Analysis (Components) |
Spirit Pharmaceuticals | Drugs | 11/01/2023 | Lack of written stability program |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Lack of Written MDR Procedures |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Evaluation of suppliers, contractors, etc., requirements |
W. A. Baum Company, Inc. | Devices | 11/06/2023 | Documentation |